-
Houthi missile attacks kill 58 Saudi-backed Yemeni govt forces: source
-
Battling Norrie survives match point to oust de Minaur
-
No.1 Sabalenka and Pegula advance at Toronto
-
US firm takes on backyard mosquitoes -- with 600,000 mosquitoes
-
China missile test top of agenda as Pacific diplomats meet in Fiji
-
Thousands protest private property legislation in Argentina
-
Most UK teens to opt out of planned social media curfew: poll
-
Battling Norrie survives match point to oust de Minaur at Montreal
-
Venezuela's political transition talks launch in Caracas
-
Venezuela's political transition talks start: AFP
-
2 killed, 13 wounded in bus blast near Syrian capital: state media
-
Real Madrid extend Vinicius deal, sign Diomande in title bid boost
-
All Blacks skipper Taylor cautiously recovering from calf strain
-
PSG sign France midfielder Akliouche from Monaco
-
UN chief denounces Russia, Ukraine for civilian deaths
-
CONMEBOL 'expresses concern regarding repeated unilateral actions' by FIFA
-
UEFA turn up the pressure on Infantino and repeat boycott threat
-
Warren coy over whether Fury-Joshua will be in UK or US
-
Rodri approves Barcelona transfer talks with Man City: Barca source to AFP
-
Taiwan blocks key bridge in drill for potential Chinese invasion
-
Venezuela unable to tally missing from cataclysmic quakes
-
Migrant children risk abuse on streets of Ceuta, aid groups warn
-
Le Court sprints to stage six Tour de France Femmes win
-
Oil price shoots up as stocks tread water
-
Doping body says Parker's positive cocaine test caused by nutritionist
-
British Grand Prix stays on MotoGP calendar until 2028
-
UEFA says boycott of World Cups stands despite FIFA backdown on private investment
-
Britain's EasyJet flies into US hands as takeover confirmed
-
Rheinmetall sales keep surging despite cancelled naval frigate project
-
Real Madrid sign Ivory Coast winger Yan Diomande
-
Pogacar teammate Del Toro gets new UAE deal after Tour podium
-
How online disinformation fuelled Ceuta migrant surge
-
Stocks tread water with earnings, tech in focus
-
Inevitable AI Group Raises $6M From Aleph to Launch AI-Native SaaS Companies
-
Forex Expo Dubai Announces Opportunity to Win Up to 150 Grams of Gold This September 2026
-
Suspected Ebola death on boat heading for DR Congo capital
-
Forlan named new Uruguay head coach
-
England selector North not 'hung up' on Stokes absence
-
UEFA chief Ceferin: 'Underdog' leader taking fight to FIFA's Infantino
-
UK Anti-Doping confirm former world champ Parker's ban lifted
-
Salah completes move to Turkey's Trabzonspor
-
French winemakers dread 'smoky taste' after wildfires
-
UK clears Paramount's takeover of Warner Bros
-
Stocks diverge with earnings, tech in focus
-
North Korea fires ballistic missile: South Korea military
-
England recall batsman Lawrence for Pakistan series
-
'Don't have to hide': Thai IDs, legal work give hope to Myanmar refugees
-
Siemens shares plunge on disappointing guidance raise
-
Stocks mixed with tech firms back under pressure
-
New Australia coach Kiss gives Japan starts to Ross, Amatosero
Most baby formula health claims not backed by science: study
The vast majority of health claims used to advertise baby formula worldwide are not supported by rigorous scientific evidence, a study said Thursday, leading researchers to urge the breast milk substitutes be sold in plain packaging.
The study comes a week after a group of doctors and scientists called for a regulatory crackdown on the $55-billion formula industry for "predatory" marketing which they said exploits the fears of new parents to convince them not to breastfeed.
Breastfeeding is widely recognised to have huge health benefits for babies. The World Health Organization and the US CDC recommend breastfeeding exclusively during the first six months of a newborn's life.
However that recommendation is followed for less than half of infants globally, according to the WHO.
Daniel Munblit, an honorary senior lecturer at Imperial College London and an author of the new study, said researchers were not on a "crusade" against infant formula, which should remain an option for mothers who cannot or choose not to breastfeed.
"But we are very much against inappropriate infant formula marketing, which provides misleading claims not backed up by solid evidence," Munblit told AFP.
Munblit and an international team of researchers looked at the health claims made for 608 products on the websites of infant formula companies in 15 countries, including the United States, India, Britain and Nigeria.
The most common claims were that formula supports brain development, strengthens immune systems and more broadly helps growth.
Half of the products did not link the claimed health benefit to a specific ingredient, according to the study published in the BMJ journal.
Three quarters did not refer to scientific evidence supporting their claims.
Of those that provided a scientific reference, more than half pointed to reviews, opinion pieces or research on animals.
Just 14 percent of the products referred to registered clinical trials on humans. However 90 percent of those trials carried a high risk of bias, including missing data or the finding not supporting the claim, the study said.
And nearly 90 percent of the clinical trials had authors who received funding from or had ties to the formula industry, it added.
- 'Distressing' -
The most commonly cited ingredient was polyunsaturated fatty acids, which is in breast milk and is considered important for brain development.
However there is no evidence of any added benefit when the ingredient is added to baby formula, according to a Cochrane systematic review.
Munblit said the health claims were mostly used to advertise premium formula products, which could be "distressing" for parents who are misled into believing the ingredients are essential but cannot afford them.
When asked what he thinks needs to be done to address the problem, Munblit was concise.
"Plain packaging," he said.
The study comes after a series of papers were published in the Lancet journal last week calling for global policy makers to end exploitative formula marketing.
WHO infant health specialist Nigel Rollins, an author of one of the Lancet papers, said busy parents "lack the time to properly scrutinise claims" about infant formula.
The new study showed that "governments and regulatory authorities must commit the necessary time and attention to review the claims of formula milk products," Rollins said in a linked BMJ editorial.
C.Kovalenko--BTB